• Je něco špatně v tomto záznamu ?

Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies

C. Ge, S. Peters, A. Olsson, L. Portengen, J. Schüz, J. Almansa, W. Ahrens, V. Bencko, S. Benhamou, P. Boffetta, B. Bueno-de-Mesquita, N. Caporaso, D. Consonni, P. Demers, E. Fabiánová, G. Fernández-Tardón, J. Field, F. Forastiere, L. Foretova,...

. 2020 ; 202 (3) : 402-411. [pub] 20200801

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027953

Rationale: Although the carcinogenicity of diesel engine exhaust has been demonstrated in multiple studies, little is known regarding exposure-response relationships associated with different exposure subgroups and different lung cancer subtypes.Objectives: We expanded on a previous pooled case-control analysis on diesel engine exhaust and lung cancer by including three additional studies and quantitative exposure assessment to evaluate lung cancer and subtype risks associated with occupational exposure to diesel exhaust characterized by elemental carbon (EC) concentrations.Methods: We used a quantitative EC job-exposure matrix for exposure assessment. Unconditional logistic regression models were used to calculate lung cancer odds ratios and 95% confidence intervals (CIs) associated with various metrics of EC exposure. Lung cancer excess lifetime risks (ELR) were calculated using life tables accounting for all-cause mortality. Additional stratified analyses by smoking history and lung cancer subtypes were performed in men.Measurements and Main Results: Our study included 16,901 lung cancer cases and 20,965 control subjects. In men, exposure response between EC and lung cancer was observed: odds ratios ranged from 1.09 (95% CI, 1.00-1.18) to 1.41 (95% CI, 1.30-1.52) for the lowest and highest cumulative exposure groups, respectively. EC-exposed men had elevated risks in all lung cancer subtypes investigated; associations were strongest for squamous and small cell carcinomas and weaker for adenocarcinoma. EC lung cancer exposure response was observed in men regardless of smoking history, including in never-smokers. ELR associated with 45 years of EC exposure at 50, 20, and 1 μg/m3 were 3.0%, 0.99%, and 0.04%, respectively, for both sexes combined.Conclusions: We observed a consistent exposure-response relationship between EC exposure and lung cancer in men. Reduction of workplace EC levels to background environmental levels will further reduce lung cancer ELR in exposed workers.

Cancer Epidemiology Unit Department of Medical Sciences University of Turin and ll Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte Torino Italy

Center for research in Epidemiology and Population Health Cancer and Environment team Inserm U1018 University Paris Sud University Paris Saclay Villejuif France

Consiglio Nazionale delle Ricerche Istituto per la Ricerca e l'Innovazione Biomedica Palermo Italy

Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Epidemiology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Faculty of Health Sciences Palacky University Olomouc Czech Republic

Fundación para la Investigación e Innovación Biomédica en el Principado de Asturias Instituto de Investigación Sanitaria del Principado Oviedo Spain

INSERM U 1018 Villejuif France

Institut für Medizinische Informatik Biometrie Epidemiologie Ludwig Maximilians University Munich Germany Institut für Epidemiologie Deutsches Forschungszentrum für Gesundheit und Umwelt Neuherberg Germany

Institut national de la recherche scientifique University of Quebec Laval Quebec Canada

Institute and Outpatient Clinic for Occupational Social and Environmental Medicine Inner City Clinic University Hospital of Munich Ludwig Maximilians Universität Munich Germany Institute of Epidemiology Helmholtz Zentrum München German Research Center for Environmental Health Neuherberg Germany Comprehensive Pneumology Center Munich Member of the German Center for Lung Research Munich Neuherberg Germany

Institute for Medical Informatics Biometry and Epidemiology University of Duisburg Essen Essen Germany

Institute for Risk Assessment Sciences Utrecht University Utrecht the Netherlands

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany

Masaryk Memorial Cancer Institute Brno Czech Republic

National Cancer Institute Bethesda Maryland

National Institute of Public Health Bucharest Romania

National Public Health Center Budapest Hungary

Occupational Cancer Research Centre Cancer Care Ontario Toronto Ontario Canada

Regional Authority of Public Health Banská Bystrica Slovakia Faculty of Health Catholic University Ružomberok Slovakia

Roy Castle Lung Cancer Research Programme Cancer Research Centre University of Liverpool Liverpool United Kingdom

Russian Cancer Research Centre Moscow Russia

The Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

The M Sklodowska Curie National Research Institute of Oncology Warsaw Poland

The National Institute for Public Health and Environmental Protection Bilthoven the Netherlands

The Nofer Institute of Occupational Medicine Lodz Poland

Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York Department of Medical and Surgical Sciences University of Bologna Bologna Italy

Univ Rennes Inserm Ecole des hautes études en santé publique UMR_S 1085 Pointe à Pitre France

University of Montreal Hospital Research Centre University of Montreal Montreal Quebec Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027953
003      
CZ-PrNML
005      
20210114152700.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1164/rccm.201911-2101OC $2 doi
035    __
$a (PubMed)32330395
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ge, Calvin $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
245    10
$a Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Exposure-Response Analysis of 14 Case-Control Studies / $c C. Ge, S. Peters, A. Olsson, L. Portengen, J. Schüz, J. Almansa, W. Ahrens, V. Bencko, S. Benhamou, P. Boffetta, B. Bueno-de-Mesquita, N. Caporaso, D. Consonni, P. Demers, E. Fabiánová, G. Fernández-Tardón, J. Field, F. Forastiere, L. Foretova, P. Guénel, P. Gustavsson, V. Janout, KH. Jöckel, S. Karrasch, M. Teresa Landi, J. Lissowska, D. Luce, D. Mates, J. McLaughlin, F. Merletti, D. Mirabelli, T. Pándics, MÉ. Parent, N. Plato, H. Pohlabeln, L. Richiardi, J. Siemiatycki, B. Świątkowska, A. Tardón, HE. Wichmann, D. Zaridze, K. Straif, H. Kromhout, R. Vermeulen,
520    9_
$a Rationale: Although the carcinogenicity of diesel engine exhaust has been demonstrated in multiple studies, little is known regarding exposure-response relationships associated with different exposure subgroups and different lung cancer subtypes.Objectives: We expanded on a previous pooled case-control analysis on diesel engine exhaust and lung cancer by including three additional studies and quantitative exposure assessment to evaluate lung cancer and subtype risks associated with occupational exposure to diesel exhaust characterized by elemental carbon (EC) concentrations.Methods: We used a quantitative EC job-exposure matrix for exposure assessment. Unconditional logistic regression models were used to calculate lung cancer odds ratios and 95% confidence intervals (CIs) associated with various metrics of EC exposure. Lung cancer excess lifetime risks (ELR) were calculated using life tables accounting for all-cause mortality. Additional stratified analyses by smoking history and lung cancer subtypes were performed in men.Measurements and Main Results: Our study included 16,901 lung cancer cases and 20,965 control subjects. In men, exposure response between EC and lung cancer was observed: odds ratios ranged from 1.09 (95% CI, 1.00-1.18) to 1.41 (95% CI, 1.30-1.52) for the lowest and highest cumulative exposure groups, respectively. EC-exposed men had elevated risks in all lung cancer subtypes investigated; associations were strongest for squamous and small cell carcinomas and weaker for adenocarcinoma. EC lung cancer exposure response was observed in men regardless of smoking history, including in never-smokers. ELR associated with 45 years of EC exposure at 50, 20, and 1 μg/m3 were 3.0%, 0.99%, and 0.04%, respectively, for both sexes combined.Conclusions: We observed a consistent exposure-response relationship between EC exposure and lung cancer in men. Reduction of workplace EC levels to background environmental levels will further reduce lung cancer ELR in exposed workers.
650    _2
$a adenokarcinom plic $x epidemiologie $7 D000077192
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a uhlík $7 D002244
650    _2
$a velkobuněčný karcinom $x epidemiologie $7 D018287
650    _2
$a malobuněčný karcinom $x epidemiologie $7 D018288
650    _2
$a spinocelulární karcinom $x epidemiologie $7 D002294
650    _2
$a kouření cigaret $x epidemiologie $7 D000073865
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a inhalační expozice $7 D019570
650    _2
$a nádory plic $x epidemiologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pracovní expozice $x statistika a číselné údaje $7 D016273
650    _2
$a odds ratio $7 D016017
650    _2
$a sexuální faktory $7 D012737
650    12
$a výfukové emise vozidel $7 D001335
651    _2
$a Kanada $x epidemiologie $7 D002170
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Peters, Susan $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Olsson, Ann $u International Agency for Research on Cancer (IARC/WHO), Lyon, France.
700    1_
$a Portengen, Lützen $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Schüz, Joachim $u International Agency for Research on Cancer (IARC/WHO), Lyon, France.
700    1_
$a Almansa, Josué $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Ahrens, Wolfgang $u Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
700    1_
$a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Benhamou, Simone $u INSERM U 1018, Villejuif, France.
700    1_
$a Boffetta, Paolo $u Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
700    1_
$a Bueno-de-Mesquita, Bas $u The National Institute for Public Health and Environmental Protection, Bilthoven, the Netherlands.
700    1_
$a Caporaso, Neil $u National Cancer Institute, Bethesda, Maryland.
700    1_
$a Consonni, Dario $u Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
700    1_
$a Demers, Paul $u Occupational Cancer Research Centre, Cancer Care Ontario, Toronto, Ontario, Canada.
700    1_
$a Fabiánová, Eleonóra $u Regional Authority of Public Health, Banská Bystrica, Slovakia. Faculty of Health, Catholic University, Ružomberok, Slovakia.
700    1_
$a Fernández-Tardón, Guillermo $u Fundación para la Investigación e Innovación Biomédica en el Principado de Asturias - Instituto de Investigación Sanitaria del Principado (FINBA-ISPA), Faculty of Medicine, University of Oviedo and Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Oviedo, Spain.
700    1_
$a Field, John $u Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom.
700    1_
$a Forastiere, Francesco $u Consiglio Nazionale delle Ricerche-Istituto per la Ricerca e l'Innovazione Biomedica (CNR-Irib), Palermo, Italy.
700    1_
$a Foretova, Lenka $u Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Guénel, Pascal $u Center for research in Epidemiology and Population Health (CESP), Cancer and Environment team, Inserm U1018, University Paris-Sud, University Paris-Saclay, Villejuif, France.
700    1_
$a Gustavsson, Per $u The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Janout, Vladimir $u Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
700    1_
$a Jöckel, Karl-Heinz $u Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany.
700    1_
$a Karrasch, Stefan $u Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Inner City Clinic, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany. Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany. Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Munich, Neuherberg, Germany.
700    1_
$a Teresa Landi, Maria $u National Cancer Institute, Bethesda, Maryland.
700    1_
$a Lissowska, Jolanta $u The M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
700    1_
$a Luce, Danièle $u Univ Rennes, Inserm, Ecole des hautes études en santé publique (EHESP), Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.
700    1_
$a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a McLaughlin, John $u Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Merletti, Franco $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy.
700    1_
$a Mirabelli, Dario $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy.
700    1_
$a Pándics, Tamás $u National Public Health Center, Budapest, Hungary.
700    1_
$a Parent, Marie-Élise $u Institut national de la recherche scientifique, University of Quebec, Laval, Quebec, Canada.
700    1_
$a Plato, Nils $u The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Pohlabeln, Hermann $u Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
700    1_
$a Richiardi, Lorenzo $u Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and ll Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte), Torino, Italy.
700    1_
$a Siemiatycki, Jack $u University of Montreal Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
700    1_
$a Świątkowska, Beata $u The Nofer Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Tardón, Adonina $u Fundación para la Investigación e Innovación Biomédica en el Principado de Asturias - Instituto de Investigación Sanitaria del Principado (FINBA-ISPA), Faculty of Medicine, University of Oviedo and Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Oviedo, Spain.
700    1_
$a Wichmann, Heinz-Erich $u Institut für Medizinische Informatik Biometrie Epidemiologie, Ludwig Maximilians University, Munich, Germany. Institut für Epidemiologie, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany; and.
700    1_
$a Zaridze, David $u Russian Cancer Research Centre, Moscow, Russia.
700    1_
$a Straif, Kurt $u International Agency for Research on Cancer (IARC/WHO), Lyon, France.
700    1_
$a Kromhout, Hans $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
700    1_
$a Vermeulen, Roel $u Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
773    0_
$w MED00000297 $t American journal of respiratory and critical care medicine $x 1535-4970 $g Roč. 202, č. 3 (2020), s. 402-411
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32330395 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152657 $b ABA008
999    __
$a ok $b bmc $g 1608288 $s 1119133
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 202 $c 3 $d 402-411 $e 20200801 $i 1535-4970 $m American journal of respiratory and critical care medicine $n Am J Respir Crit Care Med $x MED00000297
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...